HomeFOLD • NASDAQ
add
Amicus Therapeutics, Inc.
Nakaraang pagsara
$10.33
Sakop ng araw
$10.49 - $10.71
Sakop ng taon
$9.02 - $14.57
Market cap
3.17B USD
Average na Volume
2.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 110.40M | 27.97% |
Gastos sa pagpapatakbo | 118.51M | 1.54% |
Net na kita | -48.42M | 8.53% |
Net profit margin | -43.86 | 28.52% |
Kita sa bawat share | -0.02 | 88.89% |
EBITDA | -19.52M | 45.96% |
Aktuwal na % ng binabayarang buwis | -11.10% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 239.60M | -10.30% |
Kabuuang asset | 721.79M | 3.04% |
Kabuuang sagutin | 591.10M | -1.15% |
Kabuuang equity | 130.69M | — |
Natitirang share | 296.20M | — |
Presyo para makapag-book | 23.48 | — |
Return on assets | -7.23% | — |
Return on capital | -9.18% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | -48.42M | 8.53% |
Cash mula sa mga operasyon | -29.70M | -64.34% |
Cash mula sa pag-invest | 7.54M | -79.21% |
Cash mula sa financing | -13.31M | -70.08% |
Net change in cash | -37.28M | -414.15% |
Malayang cash flow | -9.95M | -701.31% |
Tungkol
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Itinatag
Peb 4, 2002
Website
Mga Empleyado
517